Literature DB >> 19153358

Progression of undiagnosed cutaneous T-cell lymphoma during efalizumab therapy.

Claudia Hernandez, Sophie M Worobec, Sujata S Gaitonde, Monika L Kiripolsky, Kristen Aquino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19153358     DOI： 10.1001/archdermatol.2008.530

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  2 in total

Review 1.  Is there truly a risk of lymphoma from biologic therapies?

Authors:  Erica Dommasch; Joel M Gelfand
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

2.  A Case of Cutaneous T-cell Lymphoma, Masquerading as Psoriasis, Was Given Etanercept and Secukinumab: Emphasizing the Need for Biopsy Confirmation before Starting Biologics.

Authors:  Abhishek De; Tanumay Raychaudhury; Murlidhar Rajagopalan; Aarti Sarda; Nidhi Sharma
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.